- Published on
Emergency and Acute Medicine – Adult Asthma
Clinical Overview
Adult asthma is a chronic inflammatory airway disorder characterized by increased expiratory resistance due to bronchospasm, mucosal edema, airway inflammation, mucus plugging, and smooth muscle hypertrophy. These processes lead to air trapping, hyperinflation, increased dead space, and progressive airway remodeling. Status asthmaticus refers to a severe exacerbation that fails to respond to standard therapy within 30–60 minutes. Patients at highest risk for life-threatening episodes include those with prior intubations or ICU admissions, chronic systemic steroid use, recent hospitalizations, poor outpatient control, advancing age, limited access to care, multiple comorbidities, and certain demographic factors.
Pathophysiology And Triggers
Asthma involves episodic and usually reversible airflow obstruction with airway hyperresponsiveness driven by a complex inflammatory cascade. Neutrophils, eosinophils, mast cells, macrophages, T lymphocytes, epithelial cells, and cytokines all contribute. Common triggers include environmental allergens such as pollen, dust mites, mold, and animal dander; viral upper respiratory infections; occupational or chemical exposures; tobacco smoke; cold air; exercise; emotional stress; hormonal variation; and medications including aspirin, NSAIDs, and beta-blockers.
Clinical Presentation
Typical symptoms include wheezing, dyspnea, chest tightness, cough, tachypnea, and tachycardia. More severe exacerbations manifest with upright or tripod positioning, accessory muscle use, diaphoresis, inability to speak full sentences, and diminished air movement. Signs of impending respiratory failure include altered mental status, extreme fatigue, and significant pulsus paradoxus.
Diagnostic Assessment
Asthma exacerbation is primarily a clinical diagnosis. Peak expiratory flow rate is useful for quantifying severity and monitoring response to therapy, with values below 100 indicating severe obstruction and values between 100 and 300 reflecting moderate disease. Serial measurements are more informative than single readings. Arterial blood gas testing is not routinely required and should not delay intervention; rising carbon dioxide levels and respiratory acidosis signal exhaustion and impending failure. Pulse oximetry values below 90 percent suggest severe distress, though normal saturation does not exclude imminent collapse. Chest radiography is reserved for selected cases such as suspected pneumonia, pneumothorax, foreign body aspiration, first-time wheezing, or poor response to therapy. ECG is considered when cardiac disease or significant tachyarrhythmia is suspected.
Differential Considerations
Conditions that may mimic asthma include allergic reactions, angioedema, COPD exacerbation, heart failure, pulmonary embolism, pneumonia, upper airway obstruction, foreign body aspiration, myocardial ischemia, and inhalational injury.
Initial Management Principles
Early recognition of severe disease, including the presence of a “quiet chest,” is critical. Immediate therapy includes supplemental oxygen, rapid initiation of inhaled beta-agonists, and early systemic corticosteroids. Intubation should be considered for progressive fatigue, worsening mental status, or refractory hypoxemia.
Emergency Department Management
Oxygen therapy should maintain saturation above 90 percent. Short-acting inhaled beta-2 agonists such as albuterol are first-line and may be administered intermittently for mild to moderate attacks or continuously for severe exacerbations. Subcutaneous beta-agonists may be used when inhaled therapy is inadequate but carry greater systemic risk. Systemic corticosteroids reduce airway inflammation and should be administered early despite delayed onset of action. Anticholinergic agents are beneficial when added to beta-agonists in moderate to severe obstruction. Magnesium sulfate may provide benefit in severe refractory asthma but is not indicated in mild disease. Aminophylline and leukotriene inhibitors are generally not recommended in the acute setting. Noninvasive ventilation and heliox may be considered selectively but should not delay definitive airway management. Ketamine is useful as an induction agent during intubation due to bronchodilatory properties, while permissive hypercapnia may be required during mechanical ventilation.
Disposition And Follow-Up
Hospital admission is indicated for patients with poor peak flow response, persistent respiratory distress, prior severe exacerbations, recent ED visits, prolonged symptoms, or inadequate outpatient support. Observation may be appropriate for moderate responders without distress. Discharge is reasonable when peak flow exceeds 70 percent of predicted, symptoms have clearly improved, lung examination demonstrates good air movement, and close follow-up within 48–72 hours is ensured.
Key Clinical Lessons And Safety Points
Altered mental status in an asthmatic patient signifies ventilatory failure until proven otherwise. Proper inhaler or nebulizer technique must be demonstrated prior to discharge, and peak flow monitoring should be encouraged. Routine intravenous fluids do not improve airway clearance in the absence of dehydration. Antibiotics are rarely indicated and should be reserved for clear evidence of bacterial infection such as pneumonia, fever with purulent sputum, or bacterial sinusitis.
Clinical Overview
Adult asthma is a chronic inflammatory airway disorder characterized by increased expiratory resistance due to bronchospasm, mucosal edema, airway inflammation, mucus plugging, and smooth muscle hypertrophy. These processes lead to air trapping, hyperinflation, increased dead space, and progressive airway remodeling. Status asthmaticus refers to a severe exacerbation that fails to respond to standard therapy within 30–60 minutes. Patients at highest risk for life-threatening episodes include those with prior intubations or ICU admissions, chronic systemic steroid use, recent hospitalizations, poor outpatient control, advancing age, limited access to care, multiple comorbidities, and certain demographic factors.
Pathophysiology And Triggers
Asthma involves episodic and usually reversible airflow obstruction with airway hyperresponsiveness driven by a complex inflammatory cascade. Neutrophils, eosinophils, mast cells, macrophages, T lymphocytes, epithelial cells, and cytokines all contribute. Common triggers include environmental allergens such as pollen, dust mites, mold, and animal dander; viral upper respiratory infections; occupational or chemical exposures; tobacco smoke; cold air; exercise; emotional stress; hormonal variation; and medications including aspirin, NSAIDs, and beta-blockers.
Clinical Presentation
Typical symptoms include wheezing, dyspnea, chest tightness, cough, tachypnea, and tachycardia. More severe exacerbations manifest with upright or tripod positioning, accessory muscle use, diaphoresis, inability to speak full sentences, and diminished air movement. Signs of impending respiratory failure include altered mental status, extreme fatigue, and significant pulsus paradoxus.
Diagnostic Assessment
Asthma exacerbation is primarily a clinical diagnosis. Peak expiratory flow rate is useful for quantifying severity and monitoring response to therapy, with values below 100 indicating severe obstruction and values between 100 and 300 reflecting moderate disease. Serial measurements are more informative than single readings. Arterial blood gas testing is not routinely required and should not delay intervention; rising carbon dioxide levels and respiratory acidosis signal exhaustion and impending failure. Pulse oximetry values below 90 percent suggest severe distress, though normal saturation does not exclude imminent collapse. Chest radiography is reserved for selected cases such as suspected pneumonia, pneumothorax, foreign body aspiration, first-time wheezing, or poor response to therapy. ECG is considered when cardiac disease or significant tachyarrhythmia is suspected.
Differential Considerations
Conditions that may mimic asthma include allergic reactions, angioedema, COPD exacerbation, heart failure, pulmonary embolism, pneumonia, upper airway obstruction, foreign body aspiration, myocardial ischemia, and inhalational injury.
Initial Management Principles
Early recognition of severe disease, including the presence of a “quiet chest,” is critical. Immediate therapy includes supplemental oxygen, rapid initiation of inhaled beta-agonists, and early systemic corticosteroids. Intubation should be considered for progressive fatigue, worsening mental status, or refractory hypoxemia.
Emergency Department Management
Oxygen therapy should maintain saturation above 90 percent. Short-acting inhaled beta-2 agonists such as albuterol are first-line and may be administered intermittently for mild to moderate attacks or continuously for severe exacerbations. Subcutaneous beta-agonists may be used when inhaled therapy is inadequate but carry greater systemic risk. Systemic corticosteroids reduce airway inflammation and should be administered early despite delayed onset of action. Anticholinergic agents are beneficial when added to beta-agonists in moderate to severe obstruction. Magnesium sulfate may provide benefit in severe refractory asthma but is not indicated in mild disease. Aminophylline and leukotriene inhibitors are generally not recommended in the acute setting. Noninvasive ventilation and heliox may be considered selectively but should not delay definitive airway management. Ketamine is useful as an induction agent during intubation due to bronchodilatory properties, while permissive hypercapnia may be required during mechanical ventilation.
Disposition And Follow-Up
Hospital admission is indicated for patients with poor peak flow response, persistent respiratory distress, prior severe exacerbations, recent ED visits, prolonged symptoms, or inadequate outpatient support. Observation may be appropriate for moderate responders without distress. Discharge is reasonable when peak flow exceeds 70 percent of predicted, symptoms have clearly improved, lung examination demonstrates good air movement, and close follow-up within 48–72 hours is ensured.
Key Clinical Lessons And Safety Points
Altered mental status in an asthmatic patient signifies ventilatory failure until proven otherwise. Proper inhaler or nebulizer technique must be demonstrated prior to discharge, and peak flow monitoring should be encouraged. Routine intravenous fluids do not improve airway clearance in the absence of dehydration. Antibiotics are rarely indicated and should be reserved for clear evidence of bacterial infection such as pneumonia, fever with purulent sputum, or bacterial sinusitis.
0 Comments
